Results 1 - 10
of
11
Global or local? Predicting secondary structure and accessibility
- in mRNAs. [Epub]. Nucleic Acids Res 2012; PMID:22373926; http:// dx.doi.org/10.1093/nar/gks181
"... accessibility in mRNAs ..."
(Show Context)
A structural interpretation of the effect of GC-content on efficiency of RNA interference
"... doi:10.1186/1471-2105-10-S1-S33 <supplement> <title> <p>Selected papers from the Seventh Asia-Pacific Bioinformatics Conference (APBC 2009)</p> </title> <editor>Michael Q Zhang, Michael S Waterman and Xuegong Zhang</editor> <note>Research</note> ..."
Abstract
-
Cited by 2 (0 self)
- Add to MetaCart
(Show Context)
doi:10.1186/1471-2105-10-S1-S33 <supplement> <title> <p>Selected papers from the Seventh Asia-Pacific Bioinformatics Conference (APBC 2009)</p> </title> <editor>Michael Q Zhang, Michael S Waterman and Xuegong Zhang</editor> <note>Research</note> </supplement> This article is available from:
unknown title
"... Approximate Bayesian feature selection on a large meta-dataset offers novel insights on factors that effect siRNA potency ..."
Abstract
- Add to MetaCart
Approximate Bayesian feature selection on a large meta-dataset offers novel insights on factors that effect siRNA potency
Microbial Cell Factories BioMed Central Review
, 2007
"... Hitting bacteria at the heart of the central dogma: sequence-specific inhibition ..."
Abstract
- Add to MetaCart
(Show Context)
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
METHOD Computational prediction of efficient splice sites for trans-splicing ribozymes
"... Group I introns have been engineered into trans-splicing ribozymes capable of replacing the 39-terminal portion of an external mRNA with their own 39-exon. Although this design makes trans-splicing ribozymes potentially useful for therapeutic application, their trans-splicing efficiency is usually t ..."
Abstract
- Add to MetaCart
(Show Context)
Group I introns have been engineered into trans-splicing ribozymes capable of replacing the 39-terminal portion of an external mRNA with their own 39-exon. Although this design makes trans-splicing ribozymes potentially useful for therapeutic application, their trans-splicing efficiency is usually too low for medical use. One factor that strongly influences trans-splicing efficiency is the position of the target splice site on the mRNA substrate. Viable splice sites are currently determined using a biochemical trans-tagging assay. Here, we propose a rapid and inexpensive alternative approach to identify efficient splice sites. This approach involves the computation of the binding free energies between ribozyme and mRNA substrate. We found that the computed binding free energies correlate well with the trans-splicing efficiency experimentally determined at 18 different splice sites on the mRNA of chloramphenicol acetyl transferase. In contrast, our results from the trans-tagging assay correlate less well with measured trans-splicing efficiency. The computed free energy components suggest that splice site efficiency depends on the following secondary structure rearrangements: hybridization of the ribozyme’s internal guide sequence (IGS) with mRNA substrate (most important), unfolding of substrate proximal to the splice site, and release of the IGS from the 39-exon (least important). The proposed computational approach can also be extended to fulfill additional design requirements of efficient trans-splicing ribozymes, such as the optimization of 39-exon and extended guide sequences.
SEE PROFILE
"... All in-text references underlined in blue are linked to publications on ResearchGate, letting you access and read them immediately. ..."
Abstract
- Add to MetaCart
(Show Context)
All in-text references underlined in blue are linked to publications on ResearchGate, letting you access and read them immediately.
©2009 The Author(s) This is an Open Access article distributed under the terms of the
"... Creative Commons Attribution Non-Commercial License ..."
offers novel insights on factors that effect siRNA potency
"... Approximate Bayesian feature selection on a large meta-dataset ..."